| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | +6.4% | +14.8% |
| Cost of Revenue | $710K | +30.5% | +23.0% |
| Gross Profit | $1.3M | -3.3% | +10.8% |
| R&D Expense | $1.1M | +19.3% | +89.4% |
| SG&A Expense | $2.7M | +3.9% | +0.1% |
| Operating Income | -$2.6M | -14.0% | -14.3% |
| Interest Expense | $71K | — | — |
| Net Income | -$4.7M | -720.0% | -27.7% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.3M | +40.2% | +4.5% |
| Inventory | $1.1M | +5.9% | -39.6% |
| Current Assets | $3.1M | +11.2% | -22.7% |
| Total Assets | $9.6M | +1.1% | -1.7% |
| Current Liabilities | $17.1M | +86.2% | -58.5% |
| Total Liabilities | $58.3M | +3.4% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.5M | — | — |
| Capital Expenditures | $11K | — | — |
| Investing Cash Flow | -$13K | — | — |
| Financing Cash Flow | $6.7M | — | — |
| Free Cash Flow | -$7.5M | — | — |
| +2.7% |
| Stockholders' Equity | -$49.6M | -4.8% | -5.4% |